MBRX Annamycin Extends Survival 60% in Metastatic Pancreatic Cancer Preclinical Models, Non-Cardiotoxic Anthracycline Shows Significant Tumor Reduction, Enhanced Tissue Accumulation vs Doxorubicin, Immune Cell Infiltration, Phase 2B/3 MIRACLE Trial Enrollment
Moleculin Biotech, Inc. · PHARMACEUTICAL PREPARATIONS · Now $2.64
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS